BNP Paribas Asset Management
VYGR icon

BNP Paribas Asset Management’s Voyager Therapeutics VYGR Stock Holding History

BNP Paribas Asset Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-59,819
Closed -$638K – 857
2020
Q3 		$638K Hold
59,819
– – ﹤0.01% 717
2020
Q2 		$755K Buy
59,819
+794
+1% +$9.24K 0.01% 647
2020
Q1 		$540K Buy
59,025
+3,313
+6% +$38K ﹤0.01% 670
2019
Q4 		$777K Buy
+55,712
New +$810K 0.01% 679

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Asset Management's VYGR Position: Q4 2020 in Review

BNP Paribas Asset Management sold out of Voyager Therapeutics (VYGR) in Q4 2020, closing a stake of 59,819 shares — an estimated $638K sold.

BNP Paribas Asset Management first reported a position in VYGR in Q4 2019 and held it in 4 quarters. The position peaked at $777K in Q4 2019. 101 funds tracked by Wall St. Rank hold VYGR as of Q4 2020.

  • BNP Paribas Asset Management reported no remaining Voyager Therapeutics position as of Q4 2020 after selling out during the quarter.
  • BNP Paribas Asset Management sold 59,819 Voyager Therapeutics shares in Q4 2020, an estimated $638K.
  • BNP Paribas Asset Management first reported a position in Voyager Therapeutics in Q4 2019 and held it in 4 quarters.
  • BNP Paribas Asset Management's Voyager Therapeutics position peaked at $777K in Q4 2019.
  • 101 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2020.

Based on BNP Paribas Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.